Patients with Hodgkin lymphomas progressing after autologous stem cell transplantation (SCT) have a very poor outcome. Our retrospective analysis confirms that reduced-intensity conditioning allogeneic SCT may be an effective salvage strategy for patients who relapse after an autologous SCT and that outcomes are similar for both sibling and matched-unrelated donor transplants. Patients with active disease at transplantation have poor outcomes.
- Brentuximab vedotin
- Refractory/relapsed HL after autologous SCT
ASJC Scopus subject areas
- Cancer Research